In the spotlight

Kajsa Larsson, CMO, on the upcoming Phase III studies of linaprazan glurate

2 Jul 2025

Highlights from the 2024 Annual Report: Interview with Kajsa Larsson. The study will involve around 500 patients from eight countries in Europe and North America, with up to 100 hospitals and clinics.

Read more

Watch the presentation from BioStock Global Forum

23 May 2025

Now you can watch the presentation from BioStock Global Forum on May 21st, held by Christer Ahlberg, CEO of Cinclus Pharma.

Read more

Interview at Redeye about the partnership with Zentiva

22 May 2025

Christer Ahlberg, CEO of Cinclus Pharma, was interviewed at Redeye about the partnership with Zentiva.

Read more